Conexeu Sciences is trading at $3.74, up +13.11%, in pre-market trading; no clear overnight company-specific catalyst has been identified.

  • The latest company press release located was dated October 6 and concerned progress toward a planned FDA 510(k) submission—not a new October 14 announcement.
  • Trading activity and volume details were unavailable.
  • The move follows a $3.31 close on October 13.